CTSD enhances the proliferation and invasiveness of NSCLC cells [27] CTSD was validated in a clinical study and could acts as a biomarker for osteosarcomas, pulmonary metastasis, and bone malignancies [28]. This evidence concerns the gene CTSD and osteosarcoma.